Adverse drug reactions monitoring to be updated

The Medicines Control Agency is introducing an updated 'yellow card' scheme for reporting suspected adverse drug reactions, designed to protect patient confidentiality. The new scheme will no longer require personal details such as a patient's name and date of birth, but will just ask for information such as a patient's ...

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here